Skip To Main Content
Assad Jalil on Muck Rack

Assad Jalil

As seen in: Nature, MDPI, Healio, Eye News, OCT News
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Assad

Contact Assad, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Timing of macular hole surgery among vitreoretinal surgeons in the UK: A national survey, review of literature and future direction

|
By Jonathan Ng, Aimee Lloyd, Tsveta Ivanova, Assad Jalil
| Nature Verified
Abstract To survey current practice and opinion regarding the timing of idiopathic full thickness macular hole (iFTMH) surgery among consultant vitreoretinal surgeons in the United Kingdom (UK), and to provide an overview of the current literature and future direction. An online survey was sent to all members of the British and Eire Association of Vitreoretinal Surgeons (BEAVRS). Literature search and analysis were conducted on studies that investigated the timing of vitrectomy surgery for iFTMH.
Open in Who Shared Issue with article?

Foveal detachment in voretigene neparvovec administration: essential step or avoidable risk? - Eye

|
By Peter Kiraly, Tsveta Ivanova, Assad Jalil
| Nature Verified
Following successful phase I/II and phase III trials of voretigene neparvovec (VN) gene replacement therapy for RPE65-mediated inherited retinal diseases (IRDs), the U.S. FDA and EMA approved the first ocular gene therapy [1]. Subsequently, more than 500 eyes have been treated only in the PERCEIVE study (data presented at Euretina 2024), with many more being treated worldwide.
Open in Who Shared Issue with article?

Real-world outcomes of Voretigene Neparvovec: a single-centre consecutive case series - Eye

|
By Assad Jalil, Mariantonia Ferrara, Graeme Black
| Nature Verified
Abstract To present functional and anatomical outcomes of subretinal therapy with Voretigene Neparvovec (VN) in patients treated in one of the four specialist UK gene therapy centres. Single-centre, retrospective case series of patients affected by an inherited retinal dystrophy (IRD) caused by a pathogenic biallelic RPE65 mutation and treated with VN.
Open in Who Shared Issue with article?
See all 8 licensed articles (9 Total)